InfuSystem (NYSEAMERICAN:INFU) Shares Pass Above 200-Day Moving Average of $0.00

Shares of InfuSystem Holdings, Inc. (NYSEAMERICAN:INFUGet Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $8.89. InfuSystem shares last traded at $8.81, with a volume of 71,942 shares trading hands.

InfuSystem Trading Up 2.8 %

The company has a current ratio of 2.08, a quick ratio of 1.66 and a debt-to-equity ratio of 0.63. The firm has a market cap of $186.60 million, a PE ratio of 293.76 and a beta of 1.24.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of InfuSystem by 2.3% during the fourth quarter. Vanguard Group Inc. now owns 1,065,298 shares of the medical instruments supplier’s stock worth $11,228,000 after buying an additional 23,976 shares in the last quarter. BlackRock Inc. increased its holdings in shares of InfuSystem by 597.8% during the second quarter. BlackRock Inc. now owns 1,029,364 shares of the medical instruments supplier’s stock worth $9,913,000 after buying an additional 881,856 shares in the last quarter. Punch & Associates Investment Management Inc. increased its holdings in shares of InfuSystem by 3.2% during the third quarter. Punch & Associates Investment Management Inc. now owns 939,918 shares of the medical instruments supplier’s stock worth $9,061,000 after buying an additional 28,807 shares in the last quarter. Meros Investment Management LP increased its holdings in shares of InfuSystem by 0.4% during the fourth quarter. Meros Investment Management LP now owns 884,090 shares of the medical instruments supplier’s stock worth $9,318,000 after buying an additional 3,709 shares in the last quarter. Finally, Wasatch Advisors Inc. increased its holdings in shares of InfuSystem by 18.6% during the first quarter. Wasatch Advisors Inc. now owns 859,679 shares of the medical instruments supplier’s stock worth $8,425,000 after buying an additional 135,076 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Company Profile

(Get Free Report)

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Read More

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.